Skip to main content
. 2022 Jun 16;8(6):e09736. doi: 10.1016/j.heliyon.2022.e09736

Figure 2.

Figure 2

Forest plot of anti-IL-5-targeting therapy effects on moderate-to-severe exacerbations (A), the time to first moderate-to-severe exacerbation (B), and exacerbations leading to an emergency department visit or hospitalization (C) in COPD patients with increased peripheral blood eosinophils. SE = standard error; RR = risk ratio; CI = confidence interval.